Induction of interleukin-15 production by HIV-1 Nef protein: A role in the proliferation of uninfected cells

被引:43
作者
Quaranta, MG
Camponeschi, B
Straface, E
Malorni, W
Viora, M
机构
[1] Ist Super Sanita, Immunol Lab, Dept Immunol, I-00161 Rome, Italy
[2] Ist Super Sanita, Dept Ultrastruct, I-00161 Rome, Italy
关键词
Nef protein; cell activation; IL-15; HIV-1;
D O I
10.1006/excr.1999.4494
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Several recent reports have provided evidence that Nef enhances human immunodeficiency virus HIV infectivity, and in vitro experiments with the nef gene have demonstrated the possible role of Nef in modulating immune responses. Exogenous Nef has been demonstrated to induce proliferation of normal human peripheral blood mononuclear cells (PBMC) and to enhance HIV-1 replication. The aim of this study was to evaluate the biological mechanisms by which Nef, used as exogenous protein, modulates cellular activation. We showed that exogenous Nef protein induces the proliferation of unstimulated and suboptimally stimulated normal human PBMC, while it has no effect on the proliferation of optimally stimulated PBMC. Moreover, the activating effect of exogenous Nef on PBMC proliferation was associated with an increase of IFN-gamma, TNF-alpha, and IL-6 production, while, surprisingly, IL-2 production was not affected by Nef. More importantly we showed, for the first time, that Nef exerts its activating effects on PBMC proliferation through IL-15 synthesis induction by monocyte/macrophage population. In conclusion, we found that exogenous Nef protein (i) induces activation of normal PBMC, increasing their proliferative response; (ii) modulates cytokine production; (iii) exerts its activating effects through IL-15 synthesis induction; and (iv) exerts these effects entering monocyte/macrophages. Our results might suggest that Nef enhances the rate of viral replication by a novel mechanism involving the production of IL-15. (C) 1999 Academic Press.
引用
收藏
页码:112 / 121
页数:10
相关论文
共 48 条
[31]   HIV-1 - THE INFECTIVE PROCESS INVIVO [J].
MCCUNE, JM .
CELL, 1991, 64 (02) :351-363
[32]   THE HUMAN IMMUNODEFICIENCY VIRUS-1 NEF GENE-PRODUCT - A POSITIVE FACTOR FOR VIRAL-INFECTION AND REPLICATION IN PRIMARY LYMPHOCYTES AND MACROPHAGES [J].
MILLER, MD ;
WARMERDAM, MT ;
GASTON, I ;
GREENE, WC ;
FEINBERG, MB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (01) :101-113
[33]   HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 NEGATIVE FACTOR IS A TRANSCRIPTIONAL SILENCER [J].
NIEDERMAN, TMJ ;
THIELAN, BJ ;
RATNER, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (04) :1128-1132
[34]   Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein [J].
Pandori, MW ;
Fitch, NJS ;
Craig, HM ;
Richman, DD ;
Spina, CA ;
Guatelli, JC .
JOURNAL OF VIROLOGY, 1996, 70 (07) :4283-4290
[35]  
PEPER RJ, 1968, J LAB CLIN MED, V72, P842
[36]   NORMAL HUMAN INTESTINAL LYMPHOCYTES-B - INCREASED ACTIVATION COMPARED WITH PERIPHERAL-BLOOD [J].
PETERS, MG ;
SECRIST, H ;
ANDERS, KR ;
NASH, GS ;
RICH, SR ;
MACDERMOTT, RP .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (06) :1827-1833
[37]   THE EFFECT OF CYTOKINES AND PHARMACOLOGICAL AGENTS ON CHRONIC HIV-INFECTION [J].
POLI, G ;
FAUCI, AS .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (02) :191-197
[38]  
Poli G., 1995, HUMAN CYTOKINES THEI, P421
[39]   IMMUNOPATHOGENIC MECHANISMS OF HIV-INFECTION - CYTOKINE INDUCTION OF HIV EXPRESSION [J].
ROSENBERG, ZF ;
FAUCI, AS .
IMMUNOLOGY TODAY, 1990, 11 (05) :176-180
[40]   EFFECT OF A LIPOPEPTIDIC FORMULATION ON MACROPHAGE ACTIVATION AND PEPTIDE PRESENTATION TO T-CELLS [J].
ROUAIX, F ;
GRASMASSE, H ;
MAZINGUE, C ;
DIESIS, E ;
RIDEL, PR ;
ESTAQUIER, J ;
CAPRON, A ;
TARTAR, A ;
AURIAULT, C .
VACCINE, 1994, 12 (13) :1209-1214